Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Radiation-induced Injuries in Patients With Rectal Cancer 1 Radiation Injuries 1 Precancerous Conditions 1 Neoplasms, Second Primary 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Head and Neck Fibrosis 1 Fibrosis 1 Erectile Dysfunction 1 Colorectal Neoplasms 1 Adenomatous Polyps 1

Interventions

Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Blood Specimen Collection 4 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 navitoclax 1 maltodextrin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 Viusid 1 Vitamin E 1 Vitamin D 1 Tenofovir 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fibrosis × alpha-Tocopherol × Clear all

NCT02898376 2018-08-08

FIBROTHERME

Institut de Cancérologie de Lorraine

Phase 3 Unknown

Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡